Blueprint Medicines Corporation (LON:0HOJ)
92.13
-3.85 (-4.02%)
At close: Feb 21, 2025
Blueprint Medicines Employees
Blueprint Medicines had 649 employees as of December 31, 2024. The number of employees decreased by 6 or -0.92% compared to the previous year.
Employees
649
Change (1Y)
-6
Growth (1Y)
-0.92%
Revenue / Employee
626.25K GBP
Profits / Employee
-82.57K GBP
Market Cap
4.66B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Blueprint Medicines News
- 18 days ago - Blueprint Medicines to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 - PRNewsWire
- 4 weeks ago - Insider Sell: Kate Haviland Sells Shares of Blueprint Medicines Corp (BPMC) - GuruFocus
- 4 weeks ago - Insider Sell: Christina Rossi Sells Shares of Blueprint Medicines Corp (BPMC) - GuruFocus
- 5 weeks ago - Blueprint Medicines Surges Over 10% as 2025 Growth Strategy Ignites Investor - GuruFocus
- 5 weeks ago - Blueprint Medicines Corp (BPMC) Unveils 2025 Growth Strategy and Promising Clinical Developments - GuruFocus
- 5 weeks ago - Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth - PRNewsWire
- 2 months ago - Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting - PRNewsWire